. His clinical and research interests include immature pulmonary circulation, hypoxic vascular modeling, and right heart dysfunction. He has received numerous international honors and awards, sits on several national and international committees as well as major grant review committees in the field of lung vascular pathobiology and pulmonary vascular disease. He currently serves on the Editorial Board for several noted journals. Dr. Stenmark has served in the capacity of both Chair of the Respiratory Integrative Biology and Translational
CTEPH centers, serve as a platform for surgical centers and facilitate training in emerging CTEPH centers, as well as to advance research and education in CTEPH.
Along with the joint Editors-in-Chief and the Senior Associate Editor, the Deputy Editors will develop and implement strategies for receiving and publishing a greater quantity and quality of manuscripts, increasing citations, and tracking manuscripts through the review process. Both have already helped expand the pool of reviewers for the journal.
Second, this is our first issue with our new publisher, SAGE Publishing. SAGE is the fifth largest journal publisher in the world and has fifty years of experience publishing journals in Medicine, Science, Technology, Social Sciences and the Humanities. Pulmonary Circulation will benefit from their wealth of knowledge and their commitment to scholarship and innovation. SAGE's online-only format reflects the changing habits of our readers-most of you now read the journal on your computers or mobile devices. SAGE posts articles within two days of acceptance as ''Express;'' thus your work is immediately available while your paper goes through the final copyediting and typesetting.
Third, in our next issue, we begin publishing articles in the new ''Leading Edge Perspectives'' category. Several presenters at the recent PVRI Annual World Congress inspired the editors to create this forum for cutting-edge ideas in basic research and clinical practice. Leading Edge Perspectives will disseminate new and original lines of thinking in basic, translational, clinical and population-science research of pulmonary vascular disease. Authors are challenged to go beyond the scope of invited reviews; instead, these shorter articles will look to the future and present new and exciting ideas in our field. Some Leading Edge Perspectives may challenge current dogma and will be considered for publication based on the scientific merit of presented. Leading Edge Perspectives will be subject to peer review. Most articles will be invited, but unsolicited articles are welcome. Please visit the Submissions Guidelines page to find out more details: https://us.sagepub.com/en-us/nam/ pulmonary-circulation/journal202599#submission-guidelines.
In June 2017, Pulmonary Circulation will receive its first Impact Factor. Here in our sixth year, we depend on your help to make the journal succeed. We encourage you to read the journal, cite articles published in the journal in your papers, and submit high-quality manuscripts to the journal. Be sure to tell your trainees and colleagues about Pulmonary Circulation so they can learn from the articles, and submit their own research for rapid review and publication.
Finally, we thank all who support the journal-members of PVRI, editorial board members, authors, reviewers and readers. You have been a critical part in creating our unique voice in the world of medical publishing, and we look forward to sharing our exciting future with you!
